RxDoctor Payments Data

Gregory Tuke

Family Medicine · Leesport, PANPI 1891750899

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,767 and has fallen 75.0% since, to $442 in 2021.

$2,975in general payments, 2019–2025

Across 205 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$530
  • AstraZeneca$516
  • GSK$389
  • Boehringer Ingelheim$224
  • Pfizer$216
  • Amgen$206
  • plus $895 from 13 others

What the payments were for

  • Food & beverage$2,93198%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,975 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania →

Other family medicine in Leesport

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →